Recent Finacing
Recent Raise
Schrödinger develops and licenses a computational platform that combines physics-based molecular simulations and machine learning for computer-aided drug design, materials discovery, and partnered therapeutic programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Schrödinger.
